BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33706310)

  • 1. Phosphorylation of S6 Protein as a Potential Biomarker in Surgically Treated Refractory Epilepsy.
    Chodraui FI; Garcia CAB; Mendes ND; Santos MV; Beggiora PS; Silva SC; Teixeira TL; da Silva Lopes L; Saggioro FP; Neder L; Machado HR
    Dev Neurosci; 2020; 42(5-6):230-236. PubMed ID: 33706310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
    Sarnat HB; Flores-Sarnat L
    Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
    J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V
    Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T; Kitaura H; Masuda H; Kameyama S; Saito Y; Sugai K; Otsuki T; Nakazawa A; Morota N; Yamamoto T; Iida K; Nakagawa M; Mizuno T; Takahashi H; Kakita A
    Neuropathology; 2015 Oct; 35(5):401-9. PubMed ID: 25950494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.
    Liu J; Reeves C; Michalak Z; Coppola A; Diehl B; Sisodiya SM; Thom M
    Acta Neuropathol Commun; 2014 Jul; 2():71. PubMed ID: 25005575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of Fragile X mental retardation protein in malformative lesions of patients with focal cortical dysplasia.
    Reynolds CD; Nolan SO; Smith GD; Jefferson TS; Hodges SL; Brewster AL; Lugo JN
    Neuroreport; 2020 Oct; 31(14):1036-1041. PubMed ID: 32833881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal Cortical Dysplasia and Refractory Epilepsy: Role of Multimodality Imaging and Outcome of Surgery.
    Jayalakshmi S; Nanda SK; Vooturi S; Vadapalli R; Sudhakar P; Madigubba S; Panigrahi M
    AJNR Am J Neuroradiol; 2019 May; 40(5):892-898. PubMed ID: 31000525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
    Miyata H; Chiang AC; Vinters HV
    Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
    Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
    Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with
    Wang Z; Huang K; Yang X; Shen K; Yang L; Ruan R; Shi X; Wang M; Zhu G; Yang M; Zhang C; Lv S; Yang H; Fan X; Liu S
    Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of neuropeptide Y receptors caused by focal cortical dysplasia in human intractable epilepsy.
    Li L; Deng J; Liu C; Luo H; Guan Y; Zhou J; Qi X; Li T; Xu ZD; Luan GM
    Oncotarget; 2016 Mar; 7(13):15329-38. PubMed ID: 26943580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients.
    Owens GC; Garcia AJ; Mochizuki AY; Chang JW; Reyes SD; Salamon N; Prins RM; Mathern GW; Fallah A
    Front Immunol; 2019; 10():121. PubMed ID: 30761153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.